Skip to main content
Premium Trial:

Request an Annual Quote

Chris Mitton and Jack Riccardi

MDNA Life Science has appointed Chris Mitton as its CEO and Jack Riccardi as its CFO, effective immediately. Mitton has replaced former interim CEO George Steinfels, who will continue to support MDNA Life Sciences as a Board Advisor.  He previously has held sales roles at Abbott and Bayer Helathcare. In addition, Mitton has held senior commercial operations leadership positions at Ipsogen, Qiagen, and Cancer Genetics. Riccardi has held CFO position in both privately held and publicly traded entities including Omni Bio Pharmaceutical, ADial Pharmaceuticals, and Modern Visuals, over the past 10 years. Prior to that, he has held strategic finance roles, including as director of strategic planning and director of finance for General Motors. 

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more